Home / About PPME / News
News
Stada and Richter to collaborate on biosimilar development
2011-09-12 German generics giant Stada Arzneimittel (Stada) and Hungary-based Gedeon Richter (Richter) announced on 30 August 2011 that the two companies have signed licence an...
Read more
Is FDA requesting too much data to allow biosimilars to succeed in the US
2011-09-12 The FDA’s recently published plans for a biosimilar approval pathway are facing increasing scrutiny. In an interview with Scientific American, Novel Health Strategie...
Read more
New Spanish prescribing laws to promote generics
2011-09-09 In an attempt to reduce the healthcare bill the Spanish government has approved new rules to force Spanish doctors to prescribe and pharmacies to dispense generic dr...
Read more
Benefits of generics called into question
2011-09-09 The benefits associated with generic prescription drugs have been called into question in an article published in the British Medical Journal (BMJ) [1].Dr Douglas Ka...
Read more
Generics manufacturers do not have to change drug safety labels in the US
2011-09-07 A landmark ruling from the US Supreme Court has decided that generic drug manufacturers do not have to change their drug’s safety label, even if stronger safety warn...
Read more
GPs in the UK to be banned from prescribing branded statins
2011-09-07 General Practitioners (GPs) in Cambridgeshire, UK, have been told by the national health service (NHS) that they are considering proposals to ban prescribing of bran...
Read more
Does switching to generic anti-epileptic drugs lead to loss of seizure control
2011-09-05 Patients with epilepsy may have a higher risk of seizures if they switch from their brand-name medication to generic anti-epileptic drugs (AEDs). This is the message...
Read more
Biosimilars approved in Europe
2011-09-05 Last update: 11 October 2011In the EU, a legal framework for approving biosimilars was established in 2003. This framework means that biosimilars can only be approve...
Read more
Need for a global pathway for biosimilars
2011-09-02 The need for access to biosimilars is global, yet the regulations are national. Issues with this approach are discussed by Dr Mark McCamish and Dr Gillian Woollett i...
Read more
Merck and Parexel form strategic alliance for biosimilars
2011-09-02 Merck Sharp and Dohme (MSD – known in the US and Canada as Merck) and Parexel, a leading global biopharmaceutical services provider, announced on 12 January 2011 tha...
Read more
Switching from a brand-name antiepileptic drug to a generic is not associated with a higher risk of seizures
2011-08-31 A report in Clinical Pharmacology and Therapeutics provides further evidence that patients with epilepsy do not have a higher risk of seizures if they switch from th...
Read more
Epilepsy: medical concerns of prescribing generics
2011-08-31 Generic economicsGeneric medications are generally cheaper than their branded product counterparts and so prescribing these is encouraged as a cost-containment strat...
Read more
Last update: 2008-09-06 | 
Go Back | 
Print View
